Eli Lilly (LLY) Q2 2025 earnings report

Eli Lilly on Thursday hiked its 2025 guidance and posted second-quarter earnings that topped estimates on strong demand for its blockbuster weight loss and diabetes drugs. The company raised its fiscal 2025 sales guidance to $60 billion to $62 billion, from a previous outlook of $58 billion to $61 billion on underlying strength across its business….

Read More

Trump’s ‘reciprocal’ tariffs come into effect, hitting dozens of U.S. trading partners

U.S. President Donald Trump speaks to reporters ahed of boarding Marine One to depart for New Jersey, at the White House in Washington, D.C., U.S., August 1, 2025. Jonathan Ernst | Reuters U.S. President Donald Trump’s so-called “reciprocal” tariffs took effect on Thursday, imposing higher duties on many of the country’s trading partners’ exports to…

Read More

Asia chipmakers wobble after Trump’s ‘100% tariffs’ on semiconductors

Asia semiconductor-related stocks traded mixed Thursday after U.S. President Donald Trump announced he would impose a 100% tariff on chip imports, with an exemption for companies that are “building in the United States.” Details on how much domestic manufacturing is required to qualify for the exemption remain unclear. Japanese semiconductor manufacturer Tokyo Electron fell over…

Read More